Target intelligence / Profile preview

MicroRNA 3198-2 (MIR3198-2)

Target
MIR3198-2
Molecular classification
microRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 3198-2 (MIR3198-2) is a human non-coding RNA gene classified as a microRNA. MicroRNAs are short, 20-24 nucleotide RNAs that mediate post-transcriptional gene silencing by guiding RNA-induced silencing complexes (RISC) to target mRNAs, resulting in their translational repression or destabilization. MIR3198-2 is processed from primary transcripts in a series of cellular steps involving Drosha and Dicer enzymes. MicroRNAs, including MIR3198-2, play roles in numerous physiological processes by regulating gene expression, but as of now, MIR3198-2 has limited direct disease association and is not itself considered a direct therapeutic or diagnostic target[1][3]. Currently, there is no evidence that MIR3198-2 is a drug target or biological marker, and its precise biological role and disease associations are minimally established. No drugs are known to interact with MIR3198-2, and it is not established as a biomarker or implicated in safety/therapeutic challenges. Hence, it is best classified as a non-coding RNA gene with potential regulatory roles, consistent with the general function of microRNAs[1][3].

Other names
hsa-mir-3198-2mir-3198-2MIR3198-2
02

Mechanism of action

not applicable; miRNAs regulate gene expression by binding to mRNA, leading to its degradation or translational inhibition

03

Biological functions

Post-transcriptional regulation of gene expressionRegulation of mRNA stability and translation
04

Disease associations

Limited evidence; associated with microcephaly according to one genetic association

Beyond the preview

Go deeper on MicroRNA 3198-2 (MIR3198-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3198-2 (MIR3198-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call